#  Alissandra Hillis 

Biological and Biomedical Sciences, Alex Toker Lab

 

 

 



   ![Alissandra Hillis](/sites/g/files/omnuum5431/files/styles/hwp_4_5__480x600/public/landrycancerbio/files/hillis_alissandra.jpeg?itok=VZMML0fu) 

 



 





 

Alissandra graduated from the Massachusetts Institute of Technology in 2018 with a Bachelor of Science in Chemistry and Biology. Alissandra spent her four years at MIT in Dr. Matthew Vander Heiden’s lab studying the role of the glycolytic enzyme, pyruvate kinase 2 (PKM2), in pancreatic cancer. To explore a more clinical approach to cancer research, Alissandra also spent a summer in Dr. David Ting’s Lab at the Massachusetts General Hospital Cancer Center where she studied pancreatic cancer exosomes. At Harvard, Alissandra joined the lab of Dr. Alex Toker with the goal of exploiting cancer signaling signatures to identify targetable vulnerabilities.